ITM11 Expanded Access Program
Published in ClinicalTrials.gov • Mar 27, 2026
Abstract
This Expanded Access Program (EAP) is intended to provide eligible participants with access to ITM-11 prior to approval by local regulatory authorities. Program availability is subject to country eligibility. The treating physician must determine, based on the individual patient´s medical history an...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!